May 7, 2026 03:18AM
May 6, 2026 04:08PM
May 6, 2026 07:06AM
Mar 18, 2026 09:21AM
Mar 16, 2026 07:52AM
Mar 9, 2026 08:19AM
Mar 6, 2026 02:19PM EyePoint Inc. (EYPT) PT Raised to $35 at Citi
Mar 5, 2026 06:52AM
Mar 4, 2026 02:56PM
Mar 4, 2026 07:03AM
Feb 17, 2026 12:57PM
Feb 5, 2026 08:54AM
Feb 2, 2026 08:39AM
Jan 7, 2026 09:55AM Mizuho: 'we again highlight EYPT as a top pick for 2026'
Jan 7, 2026 09:02AM
Jan 7, 2026 07:03AM
Jan 2, 2026 10:00PM
Dec 21, 2025 08:00PM
Dec 9, 2025 10:49AM
Dec 8, 2025 09:55AM
Nov 20, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Nov 5, 2025 07:05AM
Oct 20, 2025 06:55AM
Oct 14, 2025 04:24PM
Oct 2, 2025 06:38AM
Aug 14, 2025 01:52PM
Aug 6, 2025 07:03AM
May 30, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
May 27, 2025 12:20PM
May 16, 2025 05:35AM
May 7, 2025 07:06AM
Mar 17, 2025 10:33AM
Mar 17, 2025 10:00AM
Mar 6, 2025 07:24AM
Mar 5, 2025 07:04AM EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 14c
Feb 5, 2025 10:19AM
Feb 5, 2025 08:23AM
Feb 5, 2025 07:01AM
Jan 13, 2025 07:07AM
Jan 8, 2025 07:02AM
Jan 7, 2025 05:01AM
Dec 4, 2024 07:03AM EyePoint Pharmaceuticals (EYPT) Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration
Nov 11, 2024 08:40AM
Nov 11, 2024 07:24AM
Nov 7, 2024 05:14PM
Oct 30, 2024 06:07AM
Oct 28, 2024 05:14PM
Oct 28, 2024 02:23PM
Oct 28, 2024 10:59AM Laidlaw Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Oct 28, 2024 07:00AM

416,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All